Lipid emulsions have been associated with liver injury. Newer mixed emulsions (ML), such as SMOFlipid(R) (Fresenius Kabi, Germany), are thought to be more hepatoprotective than soybean-based emulsions (SL), such as Intralipid(R) (Baxter, U.S.A.). Pediatric studies comparing long-term use between the two are limited. This study compares the severity of hepatic injury between a prospective cohort of hospitalized children on ML (n = 20) and a historical age- and diagnosis-matched cohort of hospitalized children on SL (n = 20). Median exposure to ML and SL were 10 vs. 6 weeks (p = 0.030), respectively, at similar median lipid doses (2.2 g/kg/d vs. 2.1 g/kg/d). Using a generalized estimating equations approach, conjugated bilirubin trajectory was found to be lower in patients on ML compared to SL (p =4 weeks) to ML is associated with decreased liver injury compared to SL in hospitalized children. (C) 2017 by European Society for Pediatric Gastroenterology, Hepatology, and Nutrition and North American Society for Pediatric Gastroenterology,
from Gastroenterology via xlomafota13 on Inoreader http://ift.tt/2zKUSGm
via IFTTT
Εγγραφή σε:
Σχόλια ανάρτησης (Atom)
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου
Σημείωση: Μόνο ένα μέλος αυτού του ιστολογίου μπορεί να αναρτήσει σχόλιο.